U.S. FDA Approves Agios AQVESME (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and…
Beijing 2022 athletes first to get access to Olympic Games footage
10 December 2025 - Athletes from Beijing 2022 will be the first to…
First qualification systems for LA28 approved
10 December 2025 - The first set of qualification systems for the LA28…
Milestone Receives FDA Approval of CARDAMYST (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)
First FDA approved treatment in 30+ years for more than 2 million…
HTX Approved for Pakistan Crypto Exchange Registration
ISLAMABAD, Pakistan, Dec. 12, 2025 /PRNewswire/ -- HTX, one of the world's…
Sri Adhikari Brothers Television Network Ltd. (SABTNL) Charts New Technology-Led Future with Strategic Transformation and 50 MW AI & Green Data Centre Proposal
Sri Adhikari Brothers Television Network Ltd. (SABTNL) (BSE 530943) (NSE: SABTNL) (ISIN:…
Press Release: Sanofi and Regenerons Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria
Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the…
HKUST Receives Government’s Approval to Establish a New Medical School
Dedicated to Nurturing a New Generation of DoctorsSupporting Hong Kong Become a…
Belite Bio Announces UKs Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant
November 02, 2025 09:00 ET | Source: Belite Bio, Inc MHRA response…
Health Canada Grants Authorization for LEQEMBI (lecanemab) for the Treatment of Early Alzheimers Disease
In Canada, lecanemab is indicated for the treatment of adult patients with…